Immunosurveillance

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Cancer immunosurveillance is a process by which an organism's immune system recognizes transformed cells in order to inhibit the growth of neoplastic tissue.[1][2] It comprises the first phase of immunoediting and is also known as the elimination phase.[3]

See also[edit]

References[edit]

  1. ^ "Immunosurveillance". Nature. Retrieved 9 October 2015. 
  2. ^ Slaney, C. Y.; Rautela, J.; Parker, B. S. (23 September 2013). "The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer". Cancer Research. 73 (19): 5852–5857. doi:10.1158/0008-5472.CAN-13-1642. PMID 24062312. 
  3. ^ Dunn, Gavin P.; Old, Lloyd J.; Schreiber, Robert D. (August 2004). "The Immunobiology of Cancer Immunosurveillance and Immunoediting". Immunity. 21 (2): 137–148. doi:10.1016/j.immuni.2004.07.017. PMID 15308095.